Kiora Pharmaceuticals, Inc. (KPRX)
2.02
-0.04
(-1.94%)
USD |
NASDAQ |
Mar 03, 16:00
2.05
+0.03
(+1.49%)
Pre-Market: 20:00
Kiora Pharmaceuticals Cash from Financing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 1.349M |
| Plus Therapeutics, Inc. | 12.31M |
| Atossa Therapeutics, Inc. | 0.00 |
| Abeona Therapeutics, Inc. | 5.163M |
| Cell Source, Inc. | 0.80M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.273M |
| Cash from Investing (Quarterly) | 5.741M |
| Free Cash Flow | -10.02M |
| Free Cash Flow Per Share (Quarterly) | -0.292 |
| Free Cash Flow to Equity (Quarterly) | -1.247M |
| Free Cash Flow to Firm (Quarterly) | -1.274M |
| Free Cash Flow Yield | -127.5% |